Diabetes - Trulicity Drug Quantity Management Policy - Per Days
Cigna Drug Quantity Management policy governing maximum dispensed quantities and refill intervals for all strengths of Trulicity (dulaglutide) for covered health benefit plans administered by Cigna companies. It defines retail and home delivery maximum quantities per defined day periods and states that product is covered as medically necessary when criteria are met.
New policy created to add additional quantity limits to approve ONE claim collectively for ONE GLP-1 agonist or GLP-1/GIP agonist every 21 days at retail or home delivery.
The quantity limit of ONE claim of ONE GLP-1 agonist or GLP-1/GIP agonist to be dispensed every 21 days at retail or home delivery was removed from this policy.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.